Welcia Holdings Co., Ltd. (TSE:3141) entered into a share transfer agreement to acquire NeoPharma, Inc. and Summit Co., Ltd. on May 18, 2020. Welcia Holdings will acquire 60 shares of NeoPharma, Inc and 200 shares of Summit Co., Ltd. For the year ended September 2019, NeoPharma reported net assets of ¥796 million, total assets of ¥1 billion, sales of ¥1.27 billion, operating profit of ¥107 million, ordinary income of ¥107 million and Summit Co. reported net assets of ¥145 million, total assets of ¥322 million, sales of ¥706 million, operating income of ¥29 million, ordinary income of ¥29 million. Board of Directors of Welcia resolved this transaction. The share transfer date is planned on July 1, 2020. Welcia Holdings Co., Ltd. (TSE:3141) completed the acquisition of NeoPharma, Inc. and Summit Co., Ltd. on July 1, 2020.